NO20022869L - Kvart¶rn¶re salter av N-substituerte cykliske eller acykliske aminer som farmasöytiske midler - Google Patents

Kvart¶rn¶re salter av N-substituerte cykliske eller acykliske aminer som farmasöytiske midler

Info

Publication number
NO20022869L
NO20022869L NO20022869A NO20022869A NO20022869L NO 20022869 L NO20022869 L NO 20022869L NO 20022869 A NO20022869 A NO 20022869A NO 20022869 A NO20022869 A NO 20022869A NO 20022869 L NO20022869 L NO 20022869L
Authority
NO
Norway
Prior art keywords
pharmaceutical agents
substituted cyclic
quaternary salts
acyclic amines
acyclic
Prior art date
Application number
NO20022869A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022869D0 (no
Inventor
Lewis Siu Leung Choi
Gregory N Beatch
Clive P Page
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of NO20022869D0 publication Critical patent/NO20022869D0/no
Publication of NO20022869L publication Critical patent/NO20022869L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20022869A 1999-12-15 2002-06-14 Kvart¶rn¶re salter av N-substituerte cykliske eller acykliske aminer som farmasöytiske midler NO20022869L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292350 1999-12-15
PCT/CA2000/001507 WO2001044218A1 (en) 1999-12-15 2000-12-15 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals

Publications (2)

Publication Number Publication Date
NO20022869D0 NO20022869D0 (no) 2002-06-14
NO20022869L true NO20022869L (no) 2002-08-14

Family

ID=4164886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022869A NO20022869L (no) 1999-12-15 2002-06-14 Kvart¶rn¶re salter av N-substituerte cykliske eller acykliske aminer som farmasöytiske midler

Country Status (21)

Country Link
US (1) US20040214867A1 (cs)
EP (1) EP1278736A1 (cs)
JP (1) JP2003516982A (cs)
KR (1) KR20020075871A (cs)
CN (1) CN1423641A (cs)
AU (1) AU2334601A (cs)
BG (1) BG106814A (cs)
BR (1) BR0016430A (cs)
CZ (1) CZ20022096A3 (cs)
EE (1) EE200200316A (cs)
HU (1) HUP0204014A3 (cs)
IL (1) IL150180A0 (cs)
IS (1) IS6415A (cs)
MX (1) MXPA02006050A (cs)
NO (1) NO20022869L (cs)
NZ (1) NZ519746A (cs)
PL (1) PL355904A1 (cs)
RU (1) RU2002116211A (cs)
WO (1) WO2001044218A1 (cs)
YU (1) YU44202A (cs)
ZA (1) ZA200205568B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148057B2 (en) * 2005-06-21 2012-04-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Methods, immunoassays and devices for detection of anti-lipoidal antibodies
AU2006262280B2 (en) * 2005-06-21 2011-09-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Methods, immunoassays and devices for detection of anti-lipoidal antibodies
AU2007322033B2 (en) 2006-11-20 2013-07-11 President And Fellows Of Harvard College Methods, compositions, and kits for treating pain and pruritis
US20120172429A1 (en) 2009-07-10 2012-07-05 Woolf Clifford J Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
JP6495654B2 (ja) 2011-10-24 2019-04-03 アサナ バイオサイエンシズ，リミティド ライアビリティ カンパニー シクロヘキシルアミン類
RU2018107695A (ru) * 2015-08-03 2019-09-05 Президент Энд Феллоуз Оф Гарвард Колледж Заряженные блокаторы ионных каналов и способы их применения
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
EP3937929A4 (en) 2019-03-11 2022-12-28 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
JP7630439B2 (ja) 2019-03-11 2025-02-17 ノシオン セラピューティクス，インコーポレイテッド エステル置換イオンチャンネル遮断薬および使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP7692834B2 (ja) 2019-03-11 2025-06-16 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
CA3155568A1 (en) 2019-11-06 2021-05-14 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
IL295950A (en) 2020-03-11 2022-10-01 Nocion Therapeutics Inc Charged ion channel blockers and methods of use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060637A (en) * 1971-06-21 1977-11-29 Pierre Fabre Sa Medicaments having psychotropic properties
US4048335A (en) * 1974-06-17 1977-09-13 The Regents Of The University Of Michigan Method of inhibiting myocardial ischemia in mammals using quaternary salts
US5110977A (en) * 1990-02-14 1992-05-05 Eastman Kodak Company Ester-containing quaternary ammonium salts as adhesion improving toner charge agents
CA2095495C (en) * 1992-06-01 2002-06-04 Stephen Carl Hasselberg Assay for serum cholinesterase
US5451394A (en) * 1993-08-25 1995-09-19 Isp Van Dyk Inc. Quaternary salts of para-dialkylamino benzamide derivatives
FR2717174B1 (fr) * 1994-03-14 1996-05-31 Sanofi Sa Utilisation de pipéridinoéthyl esters de l'acide 4-amino-5-chloro-2-méthoxybenzoïque comme 5-HT4 agonistes.

Also Published As

Publication number Publication date
BG106814A (en) 2003-04-30
CN1423641A (zh) 2003-06-11
IL150180A0 (en) 2002-12-01
US20040214867A1 (en) 2004-10-28
WO2001044218A1 (en) 2001-06-21
CZ20022096A3 (cs) 2003-02-12
IS6415A (is) 2002-06-12
HUP0204014A2 (hu) 2003-03-28
JP2003516982A (ja) 2003-05-20
KR20020075871A (ko) 2002-10-07
NZ519746A (en) 2004-05-28
MXPA02006050A (es) 2004-08-23
PL355904A1 (en) 2004-05-31
EE200200316A (et) 2003-08-15
BR0016430A (pt) 2002-08-20
NO20022869D0 (no) 2002-06-14
HUP0204014A3 (en) 2005-04-28
YU44202A (sh) 2005-11-28
EP1278736A1 (en) 2003-01-29
RU2002116211A (ru) 2004-02-10
AU2334601A (en) 2001-06-25
ZA200205568B (en) 2003-10-13

Similar Documents

Publication Publication Date Title
NO20022869L (no) Kvart¶rn¶re salter av N-substituerte cykliske eller acykliske aminer som farmasöytiske midler
NO20021450D0 (no) Cykliske aminforbindelser som CCR5 antagonister
NO20002486L (no) Sykliske aminderivater og deres anvendelse som legemidler
FR15C0096I2 (fr) Derives carbamoyloxyalkyl-azolium n-substitues
NO20041609L (no) Kvaternaere ammoniumsalter av omega-aminoalkylamider av R-2-aryl-propionsyrer og farmasoytiske sammensetninger som inneholder disse
NO20014409L (no) Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase
NO20035739D0 (no) N-aroyl syklisk aminderivater som orexin reseptorantagonister
NO20020383L (no) Mutilinderivater og deres anvendelse som anti-bakterielle midler
NO20014483L (no) Aminderivater som proteaseinhibitorer
DK0850221T3 (da) Meta-guanidin-, urinstof-, thiourinstof- eller azacykliske aminobenzoesyrederivater som intergrinantagonister
NO20015365D0 (no) Piperidinderivater som er anvendbare som CCR5-antagonister
NO20035729D0 (no) Piperidinderivater som er nyttige som modulatorer av kemokin- reseptor-aktivitet
NO20021329L (no) Kinaseinhibitorer som terapeutiske midler
NO20003118L (no) Acylguanidinderivater som inhibitorer av benresorpsjon og som vitronektinreseptorantagonister
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
NO20013600L (no) Acylderivater som behandler VLA-4 relaterte lidelser
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
NO20021253D0 (no) Quinolyl propyl piperidinderivater og deres bruk som antibakterielle midler
NO20020307L (no) N-(indolkarbonyl)-piperazinderivater
NO20021565D0 (no) Bisykliske imidazo-3-yl-aminderivater
NO20054848L (no) Substituerte p-diaminobenzenderivater
NO20004261L (no) 2-aryletyl-(piperidin-4-ylmetyl)aminderivater som muscarin- reseptor antagonister
NO20021566D0 (no) Bisykliske imidazo-5-yl-aminderivater
NO20015897L (no) Indolylpiperidinderivater som antihistaminiske og antiallergiske midler
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application